Reference number : 276-2018-2019-Q4-00199, amendment number : , agreement type : C, recipient legal name : Appili Therapeutics Inc.|Appili Therapeutics Inc., recipient country : CA, recipient province : NS, recipient city : Halifax|Halifax, recipient postal code : B3H 0A8, program name english : REGI - Business Scale-up and Productivity, program name french : CERI - Expansion et productivite des entreprises, program purpose english : nan, program purpose french : nan, agreement title english : 213332, agreement title french : 213332, agreement number : 213332, agreement value : 476000.0, agreement start date : 2019-03-26, agreement end date : 2019-03-31, description english : Support the development of three novel drugs, description french : Appuyer la mise au point de trois nouveaux médicaments, expected results english : nan, expected results french : nan, additional information english : The assistance type is Unconditionally Repayable Contribution., additional information french : Le type d'aide est Contribution à remboursement inconditionnel., owner organization : acoa-apeca, owner organization title : Atlantic Canada Opportunities Agency | Agence de promotion économique du Canada atlantique